Gynuity Health Projects

Resources

Buccal misoprostol for IUFD Research Group. Buccal misoprostol for treatment of fetal death at 14-28 weeks of pregnancy: a double-blind randomized controlled trial

This study sought to assess whether buccal misoprostol is effective for treating intrauterine fetal death. The authors found that a 200 mcg dose, repeated at 6-hour intervals, was more effective than a 100 mcg dose in evacuating the uterus within 48 hours. Contraception. 2014 Mar;89(3):187-92.

Access abstract at http://www.ncbi.nlm.nih.gov/pubmed/24405797.

  • Topic: Pregnancy Failure
  • Type: Staff Publication
  • Author: Bracken, H., Ngoc, N.T., Banks, E., Blumenthal, P.D., Derman, R.J., Patel, A., Gold, M., Winikoff, B
  • Published: March 2014